skip to content

Cambridge Institute for Medical Research

 
Read more at: Recognition for CIMR PhD student

Recognition for CIMR PhD student

26 January 2023

Congratulations to Dr Miriam Lisci, a former CIMR PhD Student who has been awarded the 2021-2022 Milo Keynes Prize for Outstanding Dissertation by the Cambridge School of Clinical Medicine Degree Committee. The prize is named in honour of Dr Milo Keynes, a clinician and author who had links to Cambridge during his lifetime...


Read more at: A spotlight on rare disease

A spotlight on rare disease

28 November 2022

We were very pleased to take part in RAREfest22, a two-day science, technology, community and arts festival organised by the Cambridge Rare Disease Network , and centred on people living with rare disease. As part of the RAREfest22 talks programme, CIMR’s Prof. Evan Reid gave a well-received presentation about the links...


Read more at: Recognition for highly-cited CIMR researcher

Recognition for highly-cited CIMR researcher

16 November 2022

Professor David Rubinsztein FRS has been highlighted by Clarivate as a ‘Highly Cited Researcher’ in 2022. This is due to his highly-cited papers which rank in the top 1% by citations for field and year in the Clarivate’s Web of Science database.


Read more at: Prestigious honour for CIMR’s Director

Prestigious honour for CIMR’s Director

7 July 2022

Congratulations to CIMR Director Prof. Julian Rayner who was elected to membership of the European Molecular Biology Organisation (EMBO), a body dedicated to excellence in European life sciences. The award reflects Julian’s achievements in malaria research and his leadership across research and public engagement. Prof...


Read more at: 2022 CIMR Research Retreat

2022 CIMR Research Retreat

24 June 2022

We were very pleased to hold our first in-person CIMR Annual Research since 2019. The busy programme included talks from early-career researchers, poster presentations and an interactive session on new computational tools for structural biology.


Read more at: Election of CIMR researcher to prestigious academy

Election of CIMR researcher to prestigious academy

9 June 2022

Congratulations to CIMR's Prof. David Rubinsztein for his recent election as a member of Academia Europaea. Invited members of this pan-European Academy cover the natural sciences, the humanities and letters


Read more at: Inspiring Scientists at the Cambridge Institute for Medical Research (ISAC)

Inspiring Scientists at the Cambridge Institute for Medical Research (ISAC)

24 February 2022

Last week we were pleased to host our first ever ISAC programme in partnership with St Catharine’s College. Twelve students from Cambridgeshire 6th Form state schools took part in interactive seminars and research projects over three days at the CIMR. The final day was spent at St Catharine’s College, where the ISAC...


Read more at: A new home for some old equipment to inspire future researchers

A new home for some old equipment to inspire future researchers

7 February 2022

CIMR’s Head of Flow Cytometry, Dr Reiner Schulte recently visited Moulton School and Science College in Northampton to donate and demonstrate an old CIMR flow cytometer in the school lab. The initiative was supported by a Royal Society Partnership Grant, a scheme to fund investigative STEM projects at schools in...


Read more at: Recognition for highly-cited CIMR researcher

Recognition for highly-cited CIMR researcher

18 November 2021

Professor David Rubinsztein FRS has been highlighted by Clarivate as a ‘Highly Cited Researcher’ in 2021. This is due to his highly-cited papers which rank in the top 1% by citations for field and year in the Clarivate’s Web of Science database.


Read more at: Postdoc Appreciation Week 2021

Postdoc Appreciation Week 2021

20 September 2021

With over 70 postdocs at CIMR, we support Postdoc Appreciation Week (September 20th – 24th) and want to acknowledge the great work postdocs do as part of the bedrock of the global science effort – and especially given all the disruption being caused by the pandemic.